 Iovance Biotherapeutics, Inc. NASDAQ:IOVA Q3 2022 Results Conference Call November 3, 2022 4:30 PM ET Company Participants Sara Pellegrino - Senior Vice President of Investor Relations and Corporate Communications Frederick Vogt - Interim President and Chief Executive Officer Jean-Marc Bellemin - Chief Financial Officer Igor Bilinsky - Chief Operating Officer James Ziegler - Executive Vice President, Commercial Friedrich Finckenstein - Chief Medical Officer Madan Jagasia - Executive Vice President, Medical Affairs Conference Call Participants Michael Yee - Jefferies Tyler Van Buren - Cowen Colleen Kusy - R.W. Baird Mark Breidenbach - Oppenheimer James Gin - Wells Fargo Kelsey Goodwin - Guggenheim Operator Welcome to the Iovance Biotherapeutics Third Quarter and Year to-date 2022 Financial Results and Corporate Update Conference Call. 